MDXG Mimedx Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MDXG

Price (delayed)

$7.78

Market cap

$905.41M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.02

Enterprise value

$873.21M

MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. ...

Highlights
Mimedx Group's equity has surged by 111% QoQ and by 107% YoY
Mimedx Group's EPS has surged by 94% YoY and by 88% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.mimedx.com
Peers: MDT TFX STE ATEC

Key stats

What are the main financial stats of MDXG
Market
Shares outstanding
116.38M
Market cap
$905.41M
Enterprise value
$873.21M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
679.19
Price to sales (P/S)
2.93
EV/EBIT
200.05
EV/EBITDA
94.36
EV/Sales
2.83
Earnings
Revenue
$309.02M
EBIT
$4.37M
EBITDA
$9.25M
Free cash flow
$8.67M
Per share
EPS
-$0.02
Free cash flow per share
$0.07
Book value per share
$0.01
Revenue per share
$2.66
TBVPS
$1.41
Balance sheet
Total assets
$189.02M
Total liabilities
$95.2M
Debt
$48.97M
Equity
$1.33M
Working capital
$110.88M
Liquidity
Debt to equity
36.82
Current ratio
3.54
Quick ratio
2.98
Net debt/EBITDA
-3.48
Margins
EBITDA margin
3%
Gross margin
82.1%
Net margin
-0.8%
Operating margin
3.6%
Efficiency
Return on assets
-1.4%
Return on equity
N/A
Return on invested capital
5%
Return on capital employed
3%
Return on sales
1.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MDXG stock price

How has the Mimedx Group stock price performed over time
Intraday
-1.39%
1 week
2.77%
1 month
26.5%
1 year
151.78%
YTD
179.86%
QTD
6.72%

Financial performance

How have Mimedx Group's revenue and profit performed over time
Revenue
$309.02M
Gross profit
$253.86M
Operating income
$11.25M
Net income
-$2.54M
Gross margin
82.1%
Net margin
-0.8%
The operating income has soared by 149% YoY
The operating margin has soared by 141% YoY
The net margin has soared by 94% YoY and by 88% from the previous quarter
MDXG's net income has soared by 93% YoY and by 87% QoQ

Growth

What is Mimedx Group's growth rate over time

Valuation

What is Mimedx Group stock price valuation
P/E
N/A
P/B
679.19
P/S
2.93
EV/EBIT
200.05
EV/EBITDA
94.36
EV/Sales
2.83
Mimedx Group's EPS has surged by 94% YoY and by 88% QoQ
Mimedx Group's equity has surged by 111% QoQ and by 107% YoY
The P/S is 49% higher than the last 4 quarters average of 2.0 and 29% higher than the 5-year quarterly average of 2.3
MDXG's revenue is up by 18% YoY and by 4.8% from the previous quarter

Efficiency

How efficient is Mimedx Group business performance
MDXG's return on invested capital has surged by 131% since the previous quarter and by 114% year-on-year
Mimedx Group's return on sales has surged by 130% QoQ and by 113% YoY
MDXG's ROA has soared by 93% YoY and by 88% QoQ

Dividends

What is MDXG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MDXG.

Financial health

How did Mimedx Group financials performed over time
The total assets is 99% more than the total liabilities
The quick ratio has increased by 20% YoY and by 12% QoQ
The current ratio has increased by 19% year-on-year and by 11% since the previous quarter
Mimedx Group's equity has surged by 111% QoQ and by 107% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.